Baumgart, Daniel C <br/><br/>
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.  [electronic resource] 

 -  The American journal of gastroenterology  May 2006 
 - 1048-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9270 
<br/><br/><label>Standard No.: </label>10.1111/j.1572-0241.2006.00524.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Azathioprine--therapeutic use<br/>Colectomy<br/>Colitis, Ulcerative--drug therapy<br/>Crohn Disease--drug therapy<br/>Drug Resistance<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Male<br/>Middle Aged<br/>Pouchitis--drug therapy<br/>Remission Induction<br/>Retrospective Studies<br/>Steroids--pharmacology<br/>Tacrolimus--administration & dosage<br/>Treatment Outcome